COAs and CAS Records Shape Peptide HS Codes for U.S. Labs
Research peptides most often fall under Chapter 29 of the Harmonized Tariff Schedule of the United States as separate chemically defined organic compounds, though Chapter 30 and heading 3822 apply in narrower cases involving formulated medicaments or diagnostic reagents. Because the correct heading depends on chemical structure and documentation, importers who are unsure should request a binding ruling from U.S. Customs and Border Protection before filing an entry, using CAS numbers and analytical data to support the request.
TL;DR:
- A binding ruling request should include the CAS number, current lot specific Certificate of Analysis, analytical methods, proposed subheading, intended use, and invoice sample.
- Many FDA regulated peptide entries need a PG01 record, program and processing codes, plus intended use coding in ACE; missing fields can trigger manual review.
- Shipments valued above $2,500 require formal entry, bonding, and a full entry summary; invoices should list chemical name, CAS number, quantity, value, origin, and packaging.
- Importers should recheck ruling status and FDA data requirements before repeat shipments, since CBP can modify or revoke rulings and PGA fields can change.
Table of Contents
- How U.S. tariff classification works for peptide shipments
- What CBP ruling letters reveal about peptide classification
- How to request a binding classification ruling under 19 C.F.R. 177
- PGA filing requirements: FDA codes and ACE data for peptide entries
- Customs entry checklist for peptide shipments
- Lab documentation that supports accurate customs classification
- Recent changes affecting peptide HTS classification and rulings
- Why classification certainty is worth the upfront effort
- Documentation and support for U.S. peptide importers
- FAQ
- Sources
How U.S. tariff classification works for peptide shipments
Tariff classification under the Harmonized Tariff Schedule of the United States follows the General Rules of Interpretation, a sequential framework that starts with the terms of the heading itself and the relevant section or chapter notes. For peptides, this means classification turns on chemical identity first and commercial use second. CBP guidance confirms that when a compound is classifiable under Chapter 29 and another heading could also apply, Chapter 29 generally takes precedence for separate chemically defined compounds, which covers most synthetic research peptides with a confirmed amino acid sequence and no added excipients.
Several heading families recur in peptide entries:
- Chapter 29 subheadings in the 2930, 2933, 2934, 2935, and 2937 series cover chemically defined organic and heterocyclic compounds, including many synthetic peptides.
- Heading 3822 applies to certain diagnostic or laboratory reagents put up for use outside a chemically defined compound classification.
- Chapter 30 applies only when a product is formulated and marketed as a therapeutic medicament, a category distinct from research-use materials.
Guessing at a single “default” peptide code is risky. The right heading depends on purity, formulation, and whether the item functions as an active chemical entity or a prepared reagent kit, and that determination belongs with documented analytical evidence rather than assumption.
What CBP ruling letters reveal about peptide classification
Binding ruling letters follow a consistent structure: a statement of facts describing the product, an analysis applying the General Rules of Interpretation and relevant chapter notes, and a holding that cites the specific HTSUS subheading and applicable duty rate. Reading a handful of these letters is the fastest way for an importer to understand how CBP examiners reason about chemical identity.
- Facts sections typically quote the CAS number, molecular description, and intended use supplied by the importer.
- Analysis sections weigh chapter notes against competing headings, often distinguishing a bulk chemical from a formulated product.
- Holdings state the final subheading and duty rate, which becomes binding precedent for materially identical goods.
A representative example is ruling NY N354921, issued in November 2025, which addressed classification of a bulk pharmaceutical compound based on chemical structure and intended use rather than marketing claims. Because rulings can be modified or revoked, importers should confirm current status through the Customs Bulletin before relying on an older decision for their own entries.
How to request a binding classification ruling under 19 C.F.R. 177
Any importer, broker, or other party with a direct interest in an import transaction may request a binding ruling, and once issued, the ruling binds CBP’s treatment of materially identical merchandise until it is formally modified or revoked under eRuling requirements. For a peptide with an unusual sequence or a novel formulation, securing this certainty before the first shipment avoids a reclassification dispute after goods have already landed.
A complete ruling request should include:
- A full chemical description, including the CAS number where one exists.
- A current Certificate of Analysis confirming identity and purity.
- Analytical method descriptions, such as the HPLC method and mass spectrometry conditions used to verify the compound.
- The proposed HTSUS subheading and a statement of intended use.
- A commercial invoice sample and, where relevant, product photographs.
Requests are filed electronically through CBP’s rulings portal under 19 C.F.R. 177. CBP examiners frequently rely on the submitted analytical methods and COA to resolve chemical identity questions, so incomplete submissions tend to generate follow-up requests that extend the timeline.
Pro Tip: Attach the exact HPLC and mass spectrometry method descriptions your lab or supplier used, not just the summary purity figure. CBP examiners weigh the method as much as the result.
PGA filing requirements: FDA codes and ACE data for peptide entries
For many peptide and biological shipments, the FDA is the governing Partner Government Agency, and its data requirements flow through the Automated Commercial Environment as part of the entry filing. CBP guidance on importing biological materials confirms that FDA-regulated shipments typically require a PG01 record along with program and processing codes such as BIO, BLO, or CGT, plus an intended-use code describing the shipment’s purpose.
- The PG01 record carries the core FDA data elements tied to a specific entry line.
- A PG02 record may apply in related contexts where additional FDA detail is needed.
- Missing or inaccurate PGA data is a leading cause of entry holds, since CBP and FDA systems flag incomplete biologics or chemical filings for manual review.
Because this coding is specific to pharmaceutical and biologics entries, working with a broker experienced in that category rather than a general commodities broker meaningfully reduces the risk of a hold tied to incorrect PGA fields.
Customs entry checklist for peptide shipments
A clean entry starts with a commercial invoice that gives CBP everything it needs to classify without guessing. Build each entry line with these elements in place:
- The exact chemical or sequence name, the CAS number, quantity, unit value, and packaging description.
- Country of origin and, where the importer has already determined one, the proposed HTSUS subheading.
- A current Certificate of Analysis and supporting analytical report attached to the shipment file.
- A clear statement on the documentation that the material is “For research use only. Not for human or veterinary use,” consistent with our research-use-only compound guide.
- Confirmation of entry type: formal entry requirements apply above $2,500 in value under CBP guidance, which brings bonding and a full entry summary into play.
Pro Tip: Keep a standing file of COAs, CAS numbers, and analytical reports organized by lot number. When a broker or CBP examiner asks for backup, having it ready shortens the hold considerably.
Packaging format also matters for clearance planning. Lyophilized powders and liquid solutions carry different handling and labeling considerations, a distinction covered in our research-grade peptide formats comparison.
Lab documentation that supports accurate customs classification
We issue a batch-specific Certificate of Analysis with every order, backed by independent third-party laboratory testing, to give researchers and their customs brokers a documented basis for classification decisions. That same documentation that supports laboratory quality control also strengthens a ruling request or PGA submission.
Items worth including with a classification or ACE filing:
- A written analytical method description covering the HPLC and mass spectrometry conditions used for identity and purity confirmation.
- Purity metrics tied to a specific lot number, not a general product-line average.
- Sequence confirmation data establishing the compound as a chemically defined entity.
- Storage and stability notes relevant to how the material was handled before shipment.
Our Certificates of Analysis reference the batch and analytical method used, which gives a broker or CBP examiner a traceable chain from the invoice line to the underlying test data.
Recent changes affecting peptide HTS classification and rulings
Peptide classification has drawn closer CBP attention as the research supply chain has grown, with more entries involving custom sequences and blended formulations that do not map neatly to older ruling precedent. CBP continues to issue new ruling letters addressing specific peptide compounds, and each one adds to the body of precedent an importer can reference when preparing a classification position, which is why checking the Customs Bulletin before relying on an older ruling remains a standing practice rather than a one-time step.
On the regulatory side, FDA’s PGA data requirements within ACE have tightened over time, with more complete intended-use coding expected for biologics-adjacent entries, including many peptide shipments. Brokers who handle pharmaceutical and biologics entries regularly tend to track these PGA updates closely, since a code set that cleared smoothly a year earlier can trigger a hold if FDA’s expected fields have changed.
The practical takeaway for an importer is that classification is not a one-time determination made at the first shipment. A compound’s heading, its PGA coding requirements, and the precedent rulings that support both can shift, so revisiting the classification file periodically, particularly after a CBP revocation notice or a Customs Bulletin update, is sound practice for any lab or business importing peptides on a recurring basis.
Why classification certainty is worth the upfront effort
The importers who avoid customs delays are not the ones with the cheapest peptides. They are the ones who treated classification as a documentation problem from the first shipment: a binding ruling on file, a complete COA with every lot, and PGA codes entered correctly the first time. That discipline is not just a regulatory formality. It mirrors good laboratory practice, where traceable records exist because the science demands them, not because a form requires them. Importers who pair a specialized broker with a supplier that provides lab-grade paperwork spend far less time explaining their shipments to CBP.
— Vertex Labs Editorial Team
Documentation and support for U.S. peptide importers
We built our fulfillment process around the paperwork that customs clearance actually requires, so every order ships with the records a broker or a binding ruling request would ask for in the first place.
Each order includes:
- A batch-specific Certificate of Analysis confirming identity and purity.
- A third-party laboratory test summary tied to the same lot number.
- Sequence confirmation data suitable for attaching to a ruling request.
- Labeling and documentation stating the material is for research use only, not for human or veterinary use.
These are the same items a binding ruling request or an ACE PGA submission calls for, which means our documentation drops directly into either process without reformatting. Browse our research peptides and sterile solutions or review our Certificates of Analysis to see the format before you place an order. For Research Use Only. Not for human or veterinary use.
FAQ
What does HS code 3923.30 represent?
Plastic containers used for conveyance or packing of goods are classified separately and do not affect the classification of peptides, which are determined by chemical identity under Chapter 29 or the applicable heading, with packaging addressed separately on the entry.
What does the HS code 6309000 represent?
Worn clothing and other worn textile articles are categories unrelated to peptides or laboratory chemicals. If such codes appear alongside peptide classification queries, they indicate a mismatch and are not valid classification options for research compounds.
How do I find the correct HS code in the USA?
The authoritative source is the USITC HTS search tool, which provides current heading and subheading text along with column duty rates. For a peptide with an uncertain classification, pairing that search with a CAS number and analytical data, then confirming through a CBP binding ruling request, gives a defensible result rather than a guess.
Are peptides legal to buy in the United States?
Research-use-only peptides can be lawfully purchased and sold in the United States when marketed and sold strictly for laboratory and research applications rather than human or veterinary use. Our guide to peptide research legal boundaries covers the compliance distinctions researchers and procurement officers should understand before ordering, and a related perspective from Peppy&Me on RUO classification discusses how suppliers across the industry approach this designation.